These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2095207)

  • 1. Attachment of rhodosaminylanthracyclinone-type anthracyclines to the hinge region of monoclonal antibodies.
    Hermentin P; Doenges R; Gronski P; Bosslet K; Kraemer HP; Hoffmann D; Zilg H; Steinstraesser A; Schwarz A; Kuhlmann L
    Bioconjug Chem; 1990; 1(2):100-7. PubMed ID: 2095207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BR96 conjugates of highly potent anthracyclines.
    King HD; Staab AJ; Pham-Kaplita K; Yurgaitis D; Firestone RA; Lasch SJ; Trail PA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2119-22. PubMed ID: 12798317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents.
    Lau A; Bérubé G; Ford CH
    Bioorg Med Chem; 1995 Oct; 3(10):1299-304. PubMed ID: 8564395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC; Dong X; Gaudel G; Mitaku S; Monneret C; Gesson JP; Jacquesy JC; Mondon M; Renoux B; Andrianomenjanahary S; Michel S; Koch M; Tillequin F; Gerken M; Czech J; Straub R; Bosslet K
    J Med Chem; 1998 Sep; 41(19):3572-81. PubMed ID: 9733483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.
    Renneberg B; Li YM; Laatsch H; Fiebig HH
    Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hinge-thiol coupling of monoclonal antibody to silanized iron oxide particles and evaluation of magnetic cell depletion.
    Hermentin P; Doenges R; Franssen U; Bieva C; Vander Brugghen FJ; Stryckmans P; Friesen HJ; Optaczy B; Schneider S; Ax W
    Bioconjug Chem; 1990; 1(6):411-8. PubMed ID: 2151562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemically obtained N-demethyl derivatives of anthracyclines.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1653-61. PubMed ID: 1473993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
    Tsujisaki M; Imai K; Tokuchi S; Hanzawa Y; Ishida T; Kitagawa H; Hinoda Y; Yachi A
    Cancer Res; 1991 May; 51(10):2599-604. PubMed ID: 2021940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy: linkage of a boronated macromolecule to monoclonal antibodies directed against tumor-associated antigens.
    Alam F; Soloway AH; Barth RF; Mafune N; Adams DM; Knoth WH
    J Med Chem; 1989 Oct; 32(10):2326-30. PubMed ID: 2795606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and cytotoxic activity of some new rhodomycin derivatives bearing modifications in the sugar moiety.
    Algiannis N; Pouli N; Marakos P; Skaltsounis AL; Florent JC; Perchellet EM; Sperfslage BJ; McIlvain CJ; Perchellet JP
    J Antibiot (Tokyo); 2002 Feb; 55(2):181-90. PubMed ID: 12003000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pK
    Matyjaszczyk K; Kolonko M; Gonciarz-Dytman A; Oszczapowicz I; Łukawska M; Jawień W; Chlopicki S; Walczak M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():44-52. PubMed ID: 28599260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New monoclonal antibodies against colon cancer-associated antigens.
    Drewinko B; Yang LY; Chan J; Trujillo JM
    Cancer Res; 1986 Oct; 46(10):5137-43. PubMed ID: 2428473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of anthracycline antibiotics with biopolymers: comparative studies of DNA binding and antimicrobial activity of rhodomycin-type anthracycline antibiotics.
    Stutter E; Walter A; Fleck WF
    J Basic Microbiol; 1986; 26(10):607-20. PubMed ID: 3108489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensely potent morpholinyl anthracyclines.
    Acton EM; Tong GL; Mosher CW; Wolgemuth RL
    J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
    Kantor RR; Ng AK; Giacomini P; Ferrone S
    Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
    Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
    J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.